Results 31 to 40 of about 644,429 (317)

Myocardial infarction with myocardial rupture [PDF]

open access: yesHeart, 2003
A 76 year old man was brought in after a syncope. His past medical history included radiotherapy for lung cancer. Upon arrival, he was pale, diaphoretic, and complained …
Q H, Ly, R, Lebeau
openaire   +2 more sources

Bivalirudin during primary PCI in acute myocardial infarction. [PDF]

open access: yes, 2008
BACKGROUND: Treatment with the direct thrombin inhibitor bivalirudin, as compared with heparin plus glycoprotein IIb/IIIa inhibitors, results in similar suppression of ischemia while reducing hemorrhagic complications in patients with stable angina and ...
Kirtane, Ajay J   +15 more
core   +1 more source

Incidence and predictors of left ventricular function change following ST-segment elevation myocardial infarction

open access: yesFrontiers in Cardiovascular Medicine, 2023
AimThe purpose of the study was to assess the incidence and predictors of left ventricular function change in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI.Methods312 patients with STEMI who received primary ...
Chuanfen Liu   +14 more
doaj   +1 more source

Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. [PDF]

open access: yes, 2009
BACKGROUND: There is no consensus regarding the safety and efficacy of drug-eluting stents, as compared with bare-metal stents, in patients with ST-segment elevation myocardial infarction who are undergoing primary percutaneous coronary intervention (PCI)
Brodie, Bruce R.   +23 more
core   +1 more source

Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size [PDF]

open access: yes, 2021
Aims: Identifying novel mediators of lethal myocardial reperfusion injury that can be targeted during primary percutaneous coronary intervention (PPCI) is key to limiting the progression of patients with ST-elevated myocardial infarction (STEMI) to ...
Mangion, Kenneth   +43 more
core   +1 more source

Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundIMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) showed that adding the nonstatin ezetimibe to statin therapy further reduced cardiovascular events in patients after an acute coronary syndrome. In a prespecified
Eri Toda Kato   +9 more
doaj   +1 more source

Neuropeptide‐Y levels in ST‐segment–elevation myocardial infarction: relationship with coronary microvascular function, heart failure, and mortality

open access: yes, 2022
Background The sympathetic cotransmitter, neuropeptide Y (NPY), is released into the coronary sinus during ST‐segment–elevation myocardial infarction and can constrict the coronary microvasculature.
Choudhury, Robin P   +17 more
core   +1 more source

Altered gene expression pattern in peripheral blood mononuclear cells in patients with acute myocardial infarction. [PDF]

open access: yes, 2012
In the acute phase of STEMI, dozens of genes from several pathways linked with lipid/glucose metabolism, platelet function and atherosclerotic plaque stability show altered expression.
Burzynska, Beata   +29 more
core   +1 more source

Red blood cell eNOS is cardioprotective in acute myocardial infarction

open access: yesRedox Biology, 2022
Red blood cells (RBCs) were shown to transport and release nitric oxide (NO) bioactivity and carry an endothelial NO synthase (eNOS). However, the pathophysiological significance of RBC eNOS for cardioprotection in vivo is unknown.
Miriam M. Cortese-Krott   +17 more
doaj   +1 more source

Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction--a hospital registry-primary care linked cohort (MINAP-GPRD). [PDF]

open access: yes, 2011
AIMS: Adherence to evidence-based treatments and its consequences after acute myocardial infarction (MI) are poorly defined. We examined the extent to which clopidogrel treatment initiated in hospital is continued in primary care; the factors predictive ...
Van Staa, Tjeerd; id_orcid   +25 more
core   +1 more source

Home - About - Disclaimer - Privacy